Search Results - Amy N. Allen
- Showing 1 - 3 results of 3
-
1
-
2
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma by Patience Odeniyide, Marielle E. Yohe, Kai Pollard, Angelina V. Vaseva, Ana Calizo, Lindy Zhang, Fausto J. Rodríguez, John Gross, Amy N. Allen, Xiaolin Wan, Romel Somwar, Karisa C. Schreck, Linda Kessler, Jiawan Wang, Christine A. Pratilas
Published 2022Artigo -
3
A Secondary Mutation in<i>BRAF</i>Confers Resistance to RAF Inhibition in a<i>BRAF</i>V600E-Mutant Brain Tumor by Jiawan Wang, Zhan Yao, Philip Jonsson, Amy N. Allen, Alice Can Ran Qin, Sharmeen Uddin, Ira J. Dunkel, Mary Petriccione, Katia Manova, Sofia Haque, Marc K. Rosenblum, David J. Pisapia, Neal Rosen, Barry S. Taylor, Christine A. Pratilas
Published 2018Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Cell biology
Gene
Genetics
MAPK/ERK pathway
Medicine
Mutation
Biochemistry
Cancer
Dabrafenib
Effector
Enzyme
Farnesyltransferase
HRAS
In vivo
Internal medicine
KRAS
Kinase
Kinome
MEK inhibitor
Melanoma
Metastatic melanoma
Mutant
Neuroblastoma RAS viral oncogene homolog
Prenylation
Protein tyrosine phosphatase
Receptor
Receptor tyrosine kinase
Signal transduction